Resveratrol as an adjunct to resuscitation fluid following hemorrhage injury

白藜芦醇作为失血性损伤后复苏液的辅助剂

• 批准号: 8517149
• 负责人: Raghavan Pillai Raju
• 金额: $ 9.3万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-01 至 2013-11-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8517149
• 关键词: Accounting; Animals; Anti-Inflammatory Agents; Anti-inflammatory; Antioxidants; Attenuated; Cardiac; Cell Survival; Cells; Cessation of life; ChIP-on-chip; Control Animal; Data; Dietary Component; Dose; Down-Regulation; Enhancers; Enzymes; Free Radicals; Functional disorder; Genes; Goals; Grapes; Health; Heart; Heart Injuries; Hemorrhage; Hemorrhagic Shock; Homologous Gene; Hour; Hypoxia; In Vitro; Injury; Intestines; Ischemia; Knowledge; Left; Left Ventricular Function; Liquid substance; Liver; Longevity; Mating Types; Mediating; Mediator of activation protein; Methods; Mitochondria; Modeling; Molecular; Morbidity - disease rate; NF-kappa B; Organ; Outcome; Oxidative Phosphorylation; Pathway interactions; Performance; Perfusion; Plants; Protein Acetylation; Rattus; Regulation; Reperfusion Injury; Reperfusion Therapy; Resolution; Resuscitation; Resveratrol; Techniques; Testing; Therapeutic; Time; Tissues; Trauma; Ventricular; Work; Yeasts; base; c-myc Genes; cell injury; cytochrome c; cytokine; enzyme activity; functional genomics; heme oxygenase-1; improved; in vitro Model; in vivo; inhibitor/antagonist; liver injury; mortality; novel; oxidative damage; phytoalexin; phytoalexins; polyphenol; research study; tool; trans-resveratrol

DESCRIPTION (provided by applicant): Severe hemorrhage causes whole body hypoxia, multiple organ dysfunction and death. Fluid resuscitation is employed to restore organ perfusion and reoxygenation following hemorrhagic injury. Reoxygenation causes oxidative damage and cell and organ injury and there is a need to develop better resuscitation methods to reduce cell injury following hemorrhage. Our systematic study of mitochondrial functional genomics in the rat resulted in the identification of a novel pathway involving Sirt1 (mammalian homolog of sir2-silent mating type information regulation 2) in hemorrhagic injury. Our studies demonstrated a significant decline in Sirt1 expression following trauma-hemorrhage (T- H). Our preliminary data also indicate that resveratrol (trans-3,5,4'-trihydroxystilbene), a phytoalexin antioxidant found i grapes, and an enhancer of Sirt1 activity, reduces heart and liver injury following hemorrhage. Our objective is therefore to establish that resveratrol can be used as an adjunct to resuscitation fluid, following hemorrhage. We will also determine the molecular basis of tissue injury and resveratrol-mediated protection following T-H. Our hypothesis is that resveratrol reduces organ injury following hemorrhagic shock and therefore it can be used as an adjunct to resuscitation fluid. We will test the central hypothesis by pursuing the following four Specific Aims: (1) optimize the time and dose of resveratrol as an adjunct to resuscitation fluid, (2) establish that resveratrol improves survival and reduces organ injury following T-H. (3) determine the effect of resveratrol treatment on cellular energetics following T-H in the heart and the liver, and (4) identify the mediators and mechanism of T-H injury resolution by resveratrol using in vivo and in vitro models. We will use state-of-the-art tools and techniques such as mitochondrial functional genomics and ChIP-chip method to test the hypothesis. When the proposed studies are completed, in addition to identifying resveratrol as an adjunct to resuscitation fluid, we would have also gained new knowledge on molecular pathways involved in hemorrhage injury and their modulation by the antioxidant resveratrol.

描述（申请人提供）：严重出血导致全身缺氧、多器官功能障碍和死亡。液体复苏用于在出血性损伤后恢复器官灌注和再氧合。复氧导致氧化损伤和细胞及器官损伤，并且需要开发更好的复苏方法以减少出血后的细胞损伤。我们在大鼠线粒体功能基因组学的系统研究导致在出血性损伤中鉴定一种涉及Sirt 1（sir 2沉默交配型信息调节2的哺乳动物同源物）的新途径。我们的研究表明，创伤出血（T-H）后Sirt 1表达显著下降。我们的初步数据还表明，白藜芦醇（反式-3，5，4 '-三羟基二苯乙烯），一种在葡萄中发现的植物抗氧化剂，以及Sirt 1活性的增强剂，可以减少出血后的心脏和肝脏损伤。因此，我们的目标是确定白藜芦醇可以作为一种辅助复苏 出血后液体。我们还将确定组织损伤和白藜芦醇介导的保护T-H后的分子基础。我们的假设是，白藜芦醇减少失血性休克后的器官损伤，因此它可以用作复苏液的辅助剂。我们将通过追求以下四个具体目标来测试中心假设：（1）优化白藜芦醇作为复苏液辅助剂的时间和剂量，（2）确定白藜芦醇改善T-H后的存活率并减少器官损伤。(3)确定白藜芦醇治疗对心脏和肝脏中T-H后细胞能量学的影响，和（4）使用体内和体外模型鉴定白藜芦醇消除T-H损伤的介质和机制。我们将使用最先进的工具和技术，如线粒体功能基因组学和ChIP芯片方法来验证这一假设。当拟议的研究完成时，除了确定白藜芦醇作为复苏液的辅助剂外，我们还将获得有关出血损伤及其抗氧化剂白藜芦醇调节的分子途径的新知识。